ImmunoPrecise Antibodies (IPA) (now rebranded as MindWalk) offers bio-native AI solutions that pair a patented HYFT protocol with the proprietary LensAI platform. The result is rapid, efficient drug discovery and development that meets the needs of leading biotherapeutics companies. ImmunoPrecise Antibodies’ discovery capacities rely on a single computational language that is integrated with manufacturing at a full-stack wet lab. This gives it a unique status as a single-source provider of antibody discovery platforms.
ImmunoPrecise Antibodies
LensAI Protein Discovery and Production